一例合并休克的多发性内分泌腺瘤病1型的病例报道

龚帆, 邓阳欢, 傅华成, 米海淇, 江涛

实用休克杂志 ›› 2026, Vol. 10 ›› Issue (1) :56-58

PDF (759KB)
实用休克杂志 ›› 2026, Vol. 10 ›› Issue (1) :56-58
临床研究

一例合并休克的多发性内分泌腺瘤病1型的病例报道

    龚帆, 邓阳欢, 傅华成, 米海淇, 江涛
作者信息 +

Multiple endocrine neoplasia type 1 with shock: A case report

  • Gong Fan, Deng Yanghuan, Fu Huacheng, Mi Haiqi, Jiang Tao
Author information +
文章历史 +

摘要

多发性内分泌腺瘤病(multiple endocrine neoplasia,MEN)1型是一种常染色体显性遗传疾病,其特征为垂体、甲状旁腺、内分泌腺及胰腺中出现肿瘤。本文报道了1例出现严重休克症状的MEN1型病例。辅助检查提示:胃泌素瘤、垂体腺瘤 、甲状旁腺腺瘤。MEN1具有显著的家庭聚集性,合理运用基因检测手段对患者及其家属进行筛查,对于疾病的诊疗和预后具有重要意义。

Abstract

Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant genetic disorder, is characterized by the development of tumors in the pituitary, parathyroid, endocrine glands, and pancreas. It is also associated with an increased risk of breast cancer, as evidenced by studies indicating that female MEN1 patients have a higher relative risk of developing breast cancer compared to the general population. This article presents a case of MEN1 complicated by severe shock symptoms. Auxiliary examinations indicated the presence of gastrinoma, pituitary adenoma, and parathyroid adenoma. This disease exhibits a high degree of familial aggregation, and the judicious application of genetic testing for patients and their families holds significant importance for diagnosis, treatment, and prognosis.

关键词

多发性内分泌腺瘤病1型 / 胃泌素瘤 / 休克

Key words

Multiple Endocrine Neoplasia Type 1 / Gastrinoma / Shock

引用本文

引用格式 ▾
龚帆, 邓阳欢, 傅华成, 米海淇, 江涛. 一例合并休克的多发性内分泌腺瘤病1型的病例报道[J]. 实用休克杂志, 2026, 10(1): 56-58
Gong Fan, Deng Yanghuan, Fu Huacheng, Mi Haiqi, Jiang Tao. Multiple endocrine neoplasia type 1 with shock: A case report[J]. Journal of practical shock, 2026, 10(1): 56-58 DOI:

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1] Brandi ML,Gagel RF,Angeli A, et al.Guidelines for diagnosis and therapy of MEN type 1 and type 2[J].The Journal of clinical endocrinology and metabolism,2001,86(12):5658-5671.
[2] Lipatenkova AK,Dzeranova LK,Pigarova EA, et al.Clinical case: multiple endocrine neoplasia type 1 (MEN 1)[J].Ožirenie i Metabolizm,2012,9(4):44-47.
[3] Thakker Rajesh V,Newey Paul J,Walls Gerard V, et al.Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)[J].The Journal of clinical endocrinology and metabolism,2012,97(9):2990-3011.
[4] Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription[J]. Cell, 1999, 96(1):143-152.
[5] 李小英.多发性内分腺瘤病[J].中国实用内科杂志,2006, 26(22):1763-1766.
[6] Georgitsi Marianthi,Raitila Anniina,Karhu Auli, et al.Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.[J].The Journal of clinical endocrinology and metabolism,2007,92(8):3321-3325.
[7] 王薇茜,叶蕾,宁光.多发性内分泌腺瘤病1型相关胸腺类癌的研究进展及挑战[J].中华内分泌代谢杂志,2017,33(5):432-434.
[8] Raue Friedhelm,Frank-Raue Karin.Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma[J].Journal of the Endocrine Society,2018,2(8):933-943.
PDF (759KB)

8

访问

0

被引

详细

导航
相关文章

/